These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19335502)

  • 1. Legal concerns trigger prostate-specific antigen testing.
    Steurer J; Held U; Schmidt M; Gigerenzer G; Tag B; Bachmann LM
    J Eval Clin Pract; 2009 Apr; 15(2):390-2. PubMed ID: 19335502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practitioner-level determinants of inappropriate prostate-specific antigen screening.
    Kerfoot BP; Holmberg EF; Lawler EV; Krupat E; Conlin PR
    Arch Intern Med; 2007 Jul; 167(13):1367-72. PubMed ID: 17620529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physician clinical experience and inappropriate prostate specific antigen screening: evidence from an Asian country.
    Kuo NW; Lin HC; Lee HC
    J Urol; 2008 Nov; 180(5):1954-8; discussion 1958. PubMed ID: 18801533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study).
    Hoffman RM; Couper MP; Zikmund-Fisher BJ; Levin CA; McNaughton-Collins M; Helitzer DL; VanHoewyk J; Barry MJ
    Arch Intern Med; 2009 Sep; 169(17):1611-8. PubMed ID: 19786681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
    Culp S; Porter M
    BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Hérault].
    Jegu J; Tretarre B; Grosclaude P; Rebillard X; Bataille V; Malavaud B; Iborra F; Salama G; Rischmann P; Villers A
    Prog Urol; 2009 Jul; 19(7):487-98. PubMed ID: 19559380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing attitudes towards medical confidentiality among Swiss physicians.
    Elger BS
    J Med Ethics; 2009 Aug; 35(8):517-24. PubMed ID: 19644012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A survey of sued physicians' self-reported reactions to malpractice litigation in Iran.
    Saberi SM; Sheikhazadi A; Joghataei H; Mohammadi V; Fallahian M
    J Forensic Leg Med; 2009 Aug; 16(6):301-6. PubMed ID: 19573837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-specific antigen-based screening for prostate cancer: evidence, controversies and future perspectives.
    Ito K
    Int J Urol; 2009 May; 16(5):458-64. PubMed ID: 19341365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The problem of defensive medicine: two Italian surveys.
    Catino M; Celotti S
    Stud Health Technol Inform; 2009; 148():206-21. PubMed ID: 19745252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rural residence and prostate cancer screening with prostate-specific antigen.
    Stamatiou K; Skolarikos A
    Rural Remote Health; 2009; 9(2):1227. PubMed ID: 19594290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do patients respect the line? Transgression of boundaries reported by Swiss general practitioners.
    Hänsel A; Nübling M; Langewitz WA
    Patient Educ Couns; 2008 Sep; 72(3):424-8. PubMed ID: 18639999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defensive medicine in general practice: recent trends and the impact of the Civil Liability Act 2002 (NSW).
    Salem O; Forster C
    J Law Med; 2009 Oct; 17(2):235-48. PubMed ID: 19998593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interpretation of primary care physicians' attitude regarding rotavirus immunisation using diffusion of innovation theories.
    Agyeman P; Desgrandchamps D; Vaudaux B; Berger C; Diana A; Heininger U; Siegrist CA; Aebi C
    Vaccine; 2009 Jul; 27(35):4771-5. PubMed ID: 19540950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A model of prostate-specific antigen screening outcomes for low- to high-risk men: information to support informed choices.
    Howard K; Barratt A; Mann GJ; Patel MI
    Arch Intern Med; 2009 Sep; 169(17):1603-10. PubMed ID: 19786680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncertainty and quality of life among men undergoing active surveillance for prostate cancer in the United States and Ireland.
    Hegarty JM; Wallace M; Comber H
    Am J Mens Health; 2008 Jun; 2(2):133-42. PubMed ID: 19477777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An opinion survey among French physicians in independent practice (Winter 2007-Spring 2008)].
    Doan BD; Lévy D; Teitelbaum J; Allemand H
    Cah Sociol Demogr Med; 2009; 49(1):3-98. PubMed ID: 19485138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of fears of perceived legal consequences on general practitioners' practice in relation to defensive medicine - a cross-sectional survey in Germany.
    Goetz K; Oldenburg D; Strobel CJ; Steinhäuser J
    BMC Prim Care; 2024 Jan; 25(1):23. PubMed ID: 38216861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defensive behavior of Dutch family physicians. Widening the concept.
    Veldhuis M
    Fam Med; 1994 Jan; 26(1):27-9. PubMed ID: 8132141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicians' legal defensiveness in end-of-life treatment decisions: comparing attitudes and knowledge in states with different laws.
    McCrary SV; Swanson JW; Coulehan J; Faber-Langendoen K; Olick RS; Belling C
    J Clin Ethics; 2006; 17(1):15-26. PubMed ID: 16689110
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.